Schweizerische Morbus Crohnund Colitis ulcerosa Vereinigung Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT01908283
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Schweizerische Morbus Crohn / Colitis ulcerosa Vereinigung (SMCCV)